756 related articles for article (PubMed ID: 28742154)
1. Lipopolysaccharide inhibits myogenic differentiation of C2C12 myoblasts through the Toll-like receptor 4-nuclear factor-κB signaling pathway and myoblast-derived tumor necrosis factor-α.
Ono Y; Sakamoto K
PLoS One; 2017; 12(7):e0182040. PubMed ID: 28742154
[TBL] [Abstract][Full Text] [Related]
2. TNF alpha inhibits myogenic differentiation of C2C12 cells through NF-κB activation and impairment of IGF-1 signaling pathway.
Zhao Q; Yang ST; Wang JJ; Zhou J; Xing SS; Shen CC; Wang XX; Yue YX; Song J; Chen M; Wei YY; Zhou QP; Dai T; Song YH
Biochem Biophys Res Commun; 2015 Mar; 458(4):790-5. PubMed ID: 25686491
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization.
Langen RC; Van Der Velden JL; Schols AM; Kelders MC; Wouters EF; Janssen-Heininger YM
FASEB J; 2004 Feb; 18(2):227-37. PubMed ID: 14769817
[TBL] [Abstract][Full Text] [Related]
4. [A Cellular Pharmacological Approach to the Development of Drugs to Treat Muscle Wasting].
Sakamoto K
Yakugaku Zasshi; 2018; 138(10):1271-1275. PubMed ID: 30270271
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein.
Dogra C; Changotra H; Mohan S; Kumar A
J Biol Chem; 2006 Apr; 281(15):10327-36. PubMed ID: 16461349
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB.
Langen RC; Schols AM; Kelders MC; Wouters EF; Janssen-Heininger YM
FASEB J; 2001 May; 15(7):1169-80. PubMed ID: 11344085
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha decreases insulin-like growth factor-I messenger ribonucleic acid expression in C2C12 myoblasts via a Jun N-terminal kinase pathway.
Frost RA; Nystrom GJ; Lang CH
Endocrinology; 2003 May; 144(5):1770-9. PubMed ID: 12697682
[TBL] [Abstract][Full Text] [Related]
8. S100B protein in myoblasts modulates myogenic differentiation via NF-kappaB-dependent inhibition of MyoD expression.
Tubaro C; Arcuri C; Giambanco I; Donato R
J Cell Physiol; 2010 Apr; 223(1):270-82. PubMed ID: 20069545
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphane reduces lipopolysaccharide-induced inflammation and enhances myogenic differentiation of mouse embryonic myoblasts via the toll-like receptor 4 and NLRP3 pathways.
Wang M; Liu M; Xu W; Teng Z; Wu X; Gan L; Zhang Y
Adv Clin Exp Med; 2023 Apr; 32(4):457-467. PubMed ID: 36398371
[TBL] [Abstract][Full Text] [Related]
10. Glutathione depletion impairs myogenic differentiation of murine skeletal muscle C2C12 cells through sustained NF-kappaB activation.
Ardite E; Barbera JA; Roca J; Fernández-Checa JC
Am J Pathol; 2004 Sep; 165(3):719-28. PubMed ID: 15331397
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyethyl starch 130/0.4 exerts its anti-inflammatory effect in endotoxemic rats by inhibiting the TLR4/NF-kappaB signaling pathway.
Xie J; Lv R; Yu L; Huang W
Ann Clin Lab Sci; 2010; 40(3):240-6. PubMed ID: 20689135
[TBL] [Abstract][Full Text] [Related]
12. TAK-242, a specific inhibitor of Toll-like receptor 4 signalling, prevents endotoxemia-induced skeletal muscle wasting in mice.
Ono Y; Maejima Y; Saito M; Sakamoto K; Horita S; Shimomura K; Inoue S; Kotani J
Sci Rep; 2020 Jan; 10(1):694. PubMed ID: 31959927
[TBL] [Abstract][Full Text] [Related]
13. IFN-gamma prevents TNF-alpha-induced apoptosis in C2C12 myotubes through down-regulation of TNF-R2 and increased NF-kappaB activity.
Tolosa L; Morlá M; Iglesias A; Busquets X; Lladó J; Olmos G
Cell Signal; 2005 Nov; 17(11):1333-42. PubMed ID: 16125053
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor inducible 14 (Fn14) is required for the expression of myogenic regulatory factors and differentiation of myoblasts into myotubes. Evidence for TWEAK-independent functions of Fn14 during myogenesis.
Dogra C; Hall SL; Wedhas N; Linkhart TA; Kumar A
J Biol Chem; 2007 May; 282(20):15000-10. PubMed ID: 17383968
[TBL] [Abstract][Full Text] [Related]
15. Biomechanical signals upregulate myogenic gene induction in the presence or absence of inflammation.
Chandran R; Knobloch TJ; Anghelina M; Agarwal S
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C267-76. PubMed ID: 17392379
[TBL] [Abstract][Full Text] [Related]
16. Ion Current-Based Proteomic Profiling for Understanding the Inhibitory Effect of Tumor Necrosis Factor Alpha on Myogenic Differentiation.
Tu C; Bu Y; Vujcic M; Shen S; Li J; Qu M; Hangauer D; Clements JL; Qu J
J Proteome Res; 2016 Sep; 15(9):3147-57. PubMed ID: 27480135
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide enhances Wnt5a expression through toll-like receptor 4, myeloid differentiating factor 88, phosphatidylinositol 3-OH kinase/AKT and nuclear factor kappa B pathways in human dental pulp stem cells.
He W; Wang Z; Zhou Z; Zhang Y; Zhu Q; Wei K; Lin Y; Cooper PR; Smith AJ; Yu Q
J Endod; 2014 Jan; 40(1):69-75. PubMed ID: 24331994
[TBL] [Abstract][Full Text] [Related]
18. Euscaphic acid isolated from roots of Rosa rugosa inhibits LPS-induced inflammatory responses via TLR4-mediated NF-κB inactivation in RAW 264.7 macrophages.
Kim IT; Ryu S; Shin JS; Choi JH; Park HJ; Lee KT
J Cell Biochem; 2012 Jun; 113(6):1936-46. PubMed ID: 22234926
[TBL] [Abstract][Full Text] [Related]
19. Diarylheptanoid 1-(4-hydroxyphenyl)-7-phenyl-(6E)-6-hepten-3-one enhances C2C12 myoblast differentiation by targeting membrane estrogen receptors and activates Akt-mTOR and p38 MAPK-NF-κB signaling axes.
Tipbunjong C; Khuituan P; Kitiyanant Y; Suksamrarn A; Pholpramool C
J Nat Med; 2019 Sep; 73(4):735-744. PubMed ID: 31087251
[TBL] [Abstract][Full Text] [Related]
20. Nuclear exclusion of forkhead box O and Elk1 and activation of nuclear factor-kappaB are required for C2C12-RasV12C40 myoblast differentiation.
De Alvaro C; Nieto-Vazquez I; Rojas JM; Lorenzo M
Endocrinology; 2008 Feb; 149(2):793-801. PubMed ID: 17962350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
